Key facts
- It has raised $13.7M; the latest was Early Stage VC ($13.7M) in Apr 2025.
- Notable investors include Legend Capital, Shanghai Healthcare Capital, Xingzheng Innovation Capital, LAV (Lilly Asia Fund), Shanghai Shangshi Capital Management.
- Status: Privately Held (backing).
- ·The complete investor list — 5 names
- ·Watchlist + deal alerts for Easy-Flow Medtech
- ·The full record, as it builds
Funding rounds
No funding rounds for Easy-Flow Medtech are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Easy-Flow Medtech
Developer of medical devices used in the peripheral intervention field. The company's equipment includes drug balloons, catheters, stents, and thrombus removal devices, enabling patients to heal peripheral arterial stenosis, varicose veins, deep vein thrombosis and arteriovenous fistulas.
- Sector
- Healthcare
- HQ
- Shanghai, China
- Founded
- 2021
- Website
- easyflowmedtech.com/
- Ownership
- Privately Held (backing)
Easy-Flow Medtech doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Easy-Flow Medtech shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Easy-Flow Medtech in its N-PORT filings yet. We sweep new filings monthly.